Madrid, 6 sep (EFE).-the liraglutida, a new treatment for type 2 diabetes which is already on sale in Spanish pharmacies, it helps to lose weight and to control blood pressure, and to regulate the blood sugar.
La Dr. Susana Monereo, head of the section of Endocrinology and nutrition from the University Hospital of Getafe, Madrid, explained today, at a press conference that four Spaniards million suffer from diabetes 2, which is of itself a factor of risk cardiovascular.
Of these patients, he added, around 80% is also overweight or obese, a situation that worsens the chance of complications.
These patients goes the new drug is injected subcutaneously once a day, and independently of the meals.
“The results of clinical trials with liraglutida demonstrate that controls glucose in way maintained in time while helping to reduce the weight and the systolic, blood pressure and beneficial acts on cells of the pancreas, insulin-producing beta,” said Monereo.
He stressed that, unlike other therapies to control type 2 diabetes, whose immediate effect is the increase in volume, with liraglutida patients may lose between 10 and 15% of the weight.
Is a drug with a homology to GLP-1 (peptide glucagon type 1) nature of the Agency, a hormone secreted by the intestine, whose function is to regulate glucose levels keeping them in normal ranges.
“When we eat, the GLP-1 is released by stimulating the secretion of insulin from the pancreas and making slow gastric emptying”, commented Monereo, who added it acts also at the level of the central nervous system favouring the feeling of satiety.
Patients with diabetes type 2, it has been observed that the hormone GLP-1 is decreased, and therefore lose the ability to regulate the levels of glucose.
In his view, this double effect of control of blood glucose and weight loss that brings this therapy “is a great benefit in the control of diabetes”.
Monereo emphasised, moreover, representing greater comfort for the patient with others that require time adaptation and adjustment of dose, administered once a day independently of the meals.
Also, doesn’t require dose adjustments need not patient to daily of glucose measurements
Domingo Orozco, the Centre for health of San Blas-Unidad of investigation San family doctor Juan (Alicante, East of the country) and member of the Group of diabetes of the Spanish society of family medicine and community (semFYC), said that type 2 diabetes affects between 10 and 14% of the population of Spain.
“To increase the prevalence of obesity in our country, has increased also the 2 diabetes”, added Orozco, who recalled that overweight produces resistance to the action of insulin, which just causing the failure of the pancreas in the production of this hormone and the onset of diabetes.
The doctor stressed that small losses of kilos in patients with diabetes lower figures of blood glucose, blood pressure and lipids.
For this reason, he concluded, is so important to a person who is obese and have diabetes to get weight losses, even if they are 5%. EFE
